BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30290884)

  • 1. Fine mapping epitope on glycoprotein-Gn from Crimean-Congo hemorrhagic fever virus.
    Shalitanati A; Yu H; Liu D; Xu WX; Yue X; Guo R; Li Y; Deng F; Yang J; Zhang Y; Sun S
    Comp Immunol Microbiol Infect Dis; 2018 Aug; 59():24-31. PubMed ID: 30290884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fine mapping epitope on glycoprotein Gc from Crimean-Congo hemorrhagic fever virus.
    Zhang J; Simayi A; Wang M; Moming A; Xu W; Wang C; Li Y; Ding J; Deng F; Zhang Y; Sun S
    Comp Immunol Microbiol Infect Dis; 2019 Dec; 67():101371. PubMed ID: 31627038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fine epitope mapping of the central immunodominant region of nucleoprotein from Crimean-Congo hemorrhagic fever virus (CCHFV).
    Liu D; Li Y; Zhao J; Deng F; Duan X; Kou C; Wu T; Li Y; Wang Y; Ma J; Yang J; Hu Z; Zhang F; Zhang Y; Sun S
    PLoS One; 2014; 9(11):e108419. PubMed ID: 25365026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping of B-cell epitopes on the N- terminal and C-terminal segment of nucleocapsid protein from Crimean-Congo hemorrhagic fever virus.
    Moming A; Tuoken D; Yue X; Xu W; Guo R; Liu D; Li Y; Hu Z; Deng F; Zhang Y; Sun S
    PLoS One; 2018; 13(9):e0204264. PubMed ID: 30235312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice.
    Hinkula J; Devignot S; Åkerström S; Karlberg H; Wattrang E; Bereczky S; Mousavi-Jazi M; Risinger C; Lindegren G; Vernersson C; Paweska J; van Vuren PJ; Blixt O; Brun A; Weber F; Mirazimi A
    J Virol; 2017 May; 91(10):. PubMed ID: 28250124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitope-mapping of the glycoprotein from Crimean-Congo hemorrhagic fever virus using a microarray approach.
    Fritzen A; Risinger C; Korukluoglu G; Christova I; Corli Hitzeroth A; Viljoen N; Burt FJ; Mirazimi A; Blixt O
    PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006598. PubMed ID: 29985929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping of Antibody Epitopes on the Crimean-Congo Hemorrhagic Fever Virus Nucleoprotein.
    Lombe BP; Saito T; Miyamoto H; Mori-Kajihara A; Kajihara M; Saijo M; Masumu J; Hattori T; Igarashi M; Takada A
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35336951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleoside-Modified mRNA Vaccines Protect IFNAR
    Appelberg S; John L; Pardi N; Végvári Á; Bereczky S; Ahlén G; Monteil V; Abdurahman S; Mikaeloff F; Beattie M; Tam Y; Sällberg M; Neogi U; Weissman D; Mirazimi A
    J Virol; 2022 Feb; 96(3):e0156821. PubMed ID: 34817199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introducing of an integrated artificial neural network and Chou's pseudo amino acid composition approach for computational epitope-mapping of Crimean-Congo haemorrhagic fever virus antigens.
    Nosrati M; Mohabatkar H; Behbahani M
    Int Immunopharmacol; 2020 Jan; 78():106020. PubMed ID: 31776090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of broadly neutralizing monoclonal antibodies against Crimean-Congo hemorrhagic fever virus.
    Zivcec M; Guerrero LIW; Albariño CG; Bergeron É; Nichol ST; Spiropoulou CF
    Antiviral Res; 2017 Oct; 146():112-120. PubMed ID: 28842265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine epitope mapping of glycoprotein Gn in Guertu virus.
    Zhang J; Moming A; Yue X; Shen S; Liu D; Xu WX; Wang C; Ding J; Li Y; Deng F; Zhang Y; Sun S
    PLoS One; 2019; 14(10):e0223978. PubMed ID: 31618247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular (ticks) and serological (humans) study of Crimean-Congo hemorrhagic fever virus in the Iberian Peninsula, 2013-2015.
    Palomar AM; Portillo A; Santibáñez S; García-Álvarez L; Muñoz-Sanz A; Márquez FJ; Romero L; Eiros JM; Oteo JA
    Enferm Infecc Microbiol Clin; 2017; 35(6):344-347. PubMed ID: 28291670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational formulation and immune dynamics of a multi-peptide vaccine candidate against Crimean-Congo hemorrhagic fever virus.
    Khan MSA; Nain Z; Syed SB; Abdulla F; Moni MA; Sheam MM; Karim MM; Adhikari UK
    Mol Cell Probes; 2021 Feb; 55():101693. PubMed ID: 33388416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A competitive ELISA for species-independent detection of Crimean-Congo hemorrhagic fever virus specific antibodies.
    Schuster I; Mertens M; Köllner B; Korytář T; Keller M; Hammerschmidt B; Müller T; Tordo N; Marianneau P; Mroz C; Rissmann M; Stroh E; Dähnert L; Hammerschmidt F; Ulrich RG; Groschup MH
    Antiviral Res; 2016 Oct; 134():161-166. PubMed ID: 27623345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vesicular Stomatitis Virus-Based Vaccine Protects Mice against Crimean-Congo Hemorrhagic Fever.
    Rodriguez SE; Cross RW; Fenton KA; Bente DA; Mire CE; Geisbert TW
    Sci Rep; 2019 May; 9(1):7755. PubMed ID: 31123310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever.
    Fels JM; Maurer DP; Herbert AS; Wirchnianski AS; Vergnolle O; Cross RW; Abelson DM; Moyer CL; Mishra AK; Aguilan JT; Kuehne AI; Pauli NT; Bakken RR; Nyakatura EK; Hellert J; Quevedo G; Lobel L; Balinandi S; Lutwama JJ; Zeitlin L; Geisbert TW; Rey FA; Sidoli S; McLellan JS; Lai JR; Bornholdt ZA; Dye JM; Walker LM; Chandran K
    Cell; 2021 Jun; 184(13):3486-3501.e21. PubMed ID: 34077751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and evaluation of DNA vaccine encoding Crimean Congo hemorrhagic fever virus nucleocapsid protein, glycoprotein N-terminal and C-terminal fused with LAMP1.
    Hu YL; Zhang LQ; Liu XQ; Ye W; Zhao YX; Zhang L; Qiang ZX; Zhang LX; Lei YF; Jiang DB; Cheng LF; Zhang FL
    Front Cell Infect Microbiol; 2023; 13():1121163. PubMed ID: 37026060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crimean-Congo hemorrhagic fever: seroprevalence and risk factors among humans in Achaia, western Greece.
    Sargianou M; Panos G; Tsatsaris A; Gogos C; Papa A
    Int J Infect Dis; 2013 Dec; 17(12):e1160-5. PubMed ID: 24084247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models.
    Garrison AR; Shoemaker CJ; Golden JW; Fitzpatrick CJ; Suschak JJ; Richards MJ; Badger CV; Six CM; Martin JD; Hannaman D; Zivcec M; Bergeron E; Koehler JW; Schmaljohn CS
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005908. PubMed ID: 28922426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular localization and antigenic characterization of crimean-congo hemorrhagic fever virus glycoproteins.
    Bertolotti-Ciarlet A; Smith J; Strecker K; Paragas J; Altamura LA; McFalls JM; Frias-Stäheli N; García-Sastre A; Schmaljohn CS; Doms RW
    J Virol; 2005 May; 79(10):6152-61. PubMed ID: 15858000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.